The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

被引：0
|
作者：
Piotr Rutkowski
Elżbieta Bylina
Anna Klimczak
Tomasz Świtaj
Sławomir Falkowski
Jacek Kroc
Iwona Ługowska
Magdalena Brzeskwiniewicz
Wojciech Melerowicz
Czesław Osuch
Ewa Mierzejewska
Kacper Wasielewski
Agnieszka Woźniak
Urszula Grzesiakowska
Zbigniew I Nowecki
Janusz A Siedlecki
Janusz Limon
机构：
[1] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,Department of Soft Tissue/Bone Sarcoma and Melanoma
[2] Pfizer Poland,Department of Biology and Genetics
[3] Medical University of Gdansk,Department of General Surgery
[4] GreaterPoland Oncological Center,Department of Biostatistics
[5] Jagiellonian University,Laboratory of Experimental Oncology and Department of General Medical Oncology
[6] Medical Faculty,Department of Radiology
[7] Institute of Mother and Child,Department of Gastrointestinal Tumors
[8] KU Leuven and University Hospital,Department of Molecular Biology
[9] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[10] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[11] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
来源：
BMC Cancer | / 12卷
关键词：
Sunitinib; Genotype; GIST; Prognosis; Predictive factors; Arterial hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib
    Mohammadi, Mahmoud
    Gelderblom, Hans
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (02) : 143 - 152
  • [22] A phase II study of the KIT inhibitor XL820 in patients with advanced gastrointestinal stromal tumors (GIST) resistant to or intolerant of imatinib and/or sunitinib
    Wagner, A. J.
    Yazji, S.
    Morgan, J. A.
    Choy, E.
    George, S.
    Hohos, M.
    O'Mara, M.
    Demetri, G. D.
    EJC SUPPLEMENTS, 2008, 6 (12): : 67 - 67
  • [23] Patterns of PET response after long-term sunitinib therapy in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumors (GIST).
    Raut, C. P.
    Van Den Abbeele, A.
    Ramaiya, N.
    Morgan, J. A.
    George, S.
    Quigley, M. T.
    Dollard, A. M.
    Bertagnolli, M. M.
    Baum, C.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 531S - 531S
  • [24] Treatment of advanced gastrointestinal stromal tumors (GIST): Are results of second-line sunitinib therapy related to duration of response of first-line imatinib?
    Katz, Daniela
    Greenberg-Dotan, Sari
    Feldhamer, Ilan
    Bitterman, Haim
    Hammerman, Ariel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] EFFICACY AND TOLERABILITY OF NILOTINIB IN PATIENT WITH IMATINIB AND SUNITINIB RESISTANT GASTROINTESTINAL STROMAL TUMORS (GIST): A CASE REPORT
    Pace, R.
    Amarisse, M.
    Cigliano, L.
    Rauco, A. M.
    De Santis, G.
    Capparella, V
    Liberati, F.
    Lugini, A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [26] PHASE I TRIAL OF SUNITINIB PLUS IMATINIB IN PATIENTS WITH METASTATIC OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS (GIST)
    Lopez Pousa, A.
    Paz-Ares, L.
    Pericay, C.
    Garcia Del Muro, X.
    Flor, M. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 235 - 235
  • [27] Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
    Fiore, M.
    Palassini, E.
    Fumagalli, E.
    Pilotti, S.
    Tamborini, E.
    Stacchiotti, S.
    Pennacchioli, E.
    Casali, P. G.
    Gronchi, A.
    EJSO, 2009, 35 (07): : 739 - 745
  • [28] Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
    Rutkowski, Piotr
    Gronchi, Alessandro
    Hohenberger, Peter
    Bonvalot, Sylvie
    Schoffski, Patrick
    Bauer, Sebastian
    Fumagalli, Elena
    Nyckowski, Pawel
    Buu-Phuc Nguyen
    Kerst, Jan Martijn
    Fiore, Marco
    Bylina, Elzbieta
    Hoiczyk, Mathias
    Cats, Annemieke
    Casali, Paolo G.
    Le Cesne, Axel
    Treckmann, Juergen
    Stoeckle, Eberhard
    de Wilt, Johannes. H. W.
    Sleijfer, Stefan
    Tielen, Ronald
    van der Graaf, Winette
    Verhoef, Cornelis
    van Coevorden, Frits
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (09) : 2937 - 2943
  • [29] Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
    Piotr Rutkowski
    Alessandro Gronchi
    Peter Hohenberger
    Sylvie Bonvalot
    Patrick Schöffski
    Sebastian Bauer
    Elena Fumagalli
    Pawel Nyckowski
    Buu-Phuc Nguyen
    Jan Martijn Kerst
    Marco Fiore
    Elzbieta Bylina
    Mathias Hoiczyk
    Annemieke Cats
    Paolo G. Casali
    Axel Le Cesne
    Jürgen Treckmann
    Eberhard Stoeckle
    Johannes. H. W. de Wilt
    Stefan Sleijfer
    Ronald Tielen
    Winette van der Graaf
    Cornelis Verhoef
    Frits van Coevorden
    Annals of Surgical Oncology, 2013, 20 : 2937 - 2943
  • [30] Surgery of residual disease following imatinib mesylate in advanced gastrointestinal stromal tumors (GIST).
    Gronchi, A
    Fiore, M
    Bertulli, R
    Colecchia, M
    Tamborini, E
    Pilotti, S
    Messina, A
    Coco, P
    Stacchiotti, S
    Casali, PG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 825S - 825S
12345